GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Days Payable

United Laboratories International Holdings (FRA:UNJ) Days Payable : 201.27 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Days Payable?

United Laboratories International Holdings's average Accounts Payable for the six months ended in Dec. 2023 was €526 Mil. United Laboratories International Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was €477 Mil. Hence, United Laboratories International Holdings's Days Payable for the six months ended in Dec. 2023 was 201.27.

The historical rank and industry rank for United Laboratories International Holdings's Days Payable or its related term are showing as below:

FRA:UNJ' s Days Payable Range Over the Past 10 Years
Min: 162.45   Med: 217.96   Max: 297.46
Current: 193.98

During the past 13 years, United Laboratories International Holdings's highest Days Payable was 297.46. The lowest was 162.45. And the median was 217.96.

FRA:UNJ's Days Payable is ranked better than
82.26% of 975 companies
in the Drug Manufacturers industry
Industry Median: 87.13 vs FRA:UNJ: 193.98

United Laboratories International Holdings's Days Payable declined from Dec. 2022 (227.47) to Dec. 2023 (201.27). It may suggest that United Laboratories International Holdings accelerated paying its suppliers.


United Laboratories International Holdings Days Payable Historical Data

The historical data trend for United Laboratories International Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Days Payable Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 174.18 169.34 175.15 196.49 196.47

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 218.88 248.03 227.47 190.04 201.27

Competitive Comparison of United Laboratories International Holdings's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Days Payable falls into.



United Laboratories International Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

United Laboratories International Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (481.827 + 541.976) / 2 ) / 951.013*365
=511.9015 / 951.013*365
=196.47

United Laboratories International Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (509.494 + 541.976) / 2 ) / 476.701*365 / 2
=525.735 / 476.701*365 / 2
=201.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines